West Pharmaceutical Services Inc
West Pharmaceutical Services Inc/ US9553061055 /
WST
|
2024-04-25 9:59:58 PM
|
Chg.
-17.12
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
368.42USD
|
-4.44%
|
31,286
Turnover: 11.66 mill. |
-Bid Size: - |
-Ask Size: - |
26.99 bill.USD |
0.21% |
46.14 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
7.98 USD |
1.40% |
| EPS Diluted: |
7.88 USD |
1.94% |
| Revenues per Share: |
40.24 USD |
3.34% |
| Book Value per Share: |
39.30 USD |
8.53% |
| Cash Flow per Share: |
10.59 USD |
8.48% |
| Dividend per Share: |
0.78 USD |
5.41% |
| Total |
in mill. |
|
| Revenues: |
2,949.80 USD |
2.18% |
| Net Income: |
593.40 USD |
1.28% |
| Operating Cash Flow: |
776.50 USD |
- |
| Cash and Cash Equivalents: |
853.90 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
46.14 |
44.13 |
| P/S Ratio: |
9.15 |
8.75 |
| P/BV ratio: |
9.37 |
8.96 |
| P/CF Ratio: |
34.76 |
33.24 |
| PEG: |
33.01 |
31.57 |
| Earnings Yield: |
2.17% |
2.27% |
| Dividend Yield: |
0.21% |
0.22% |
| Market Capitalization |
|
| Market Capitalization: |
26.99 bill. USD |
25.81 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
73.3 mill. |
|
Profitability
| Gross Profit Margin: |
38.28% |
| EBIT Margin: |
22.92% |
| Net Profit Margin: |
20.12% |
| Return on Equity: |
20.60% |
| Return on Assets: |
15.50% |
Financial Strength
| Liquidity I / Cash Ratio: |
127.11% |
| Liquidity II / Quick Ratio: |
203.32% |
| Liquidity III / Current Ratio: |
288.24% |
| Debt / Equity Ratio: |
32.92% |
| Dynam. Debt / Equity Ratio: |
122.15% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
US GAAP |
